Identity
BPC-157 confirmedLC-MS identity result
COMPOUND IQRESEARCH. TESTED. EXPLAINED.Scan your COADOCUMENT REVIEW · SEPTEMBER 2026
Prime Peptides BPC-157: six documented categories, one missing panel.
We reviewed Freedom Diagnostics certificate accession 2609010004 for Prime Peptides BPC-157 10 mg, lot 26082901, reported September 3, 2026.
Compound IQ has no affiliate, sponsorship, compensation, or commercial relationship with Prime Peptides. We did not purchase or independently test this lot. This review evaluates one public supplier record and its linked laboratory certificate—not the company’s entire catalog or the product’s suitability for any use.
WHAT THE CERTIFICATE REPORTS
6 of 7 evidence categories documented.
Prime Peptides’ testing page and the Freedom Diagnostics certificate align on the client, product, 10 mg label, lot, 99.63% purity result, 11.08 mg net content, and September 3 report date. Reference: ACCESSION 2609010004 · LOT 26082901 · CODE Prim2609010004.
✓
Purity
99.63%HPLC with UV detectionMeasured quantity
11.08 mgNet-content result for a sample labeled 10 mgLot traceability
26082901Client, product, lot, accession, search code, receipt date, and report date appearSterility
No detectable microbial DNAPCR-based screen targeting common microbial contaminantsEndotoxin
PassUSP <85>-referenced LAL assay · sensitivity ≤0.05 EU/mLContaminants
Not reportedNo heavy-metal, residual-solvent, adulterant, or broader contaminant panelMEASURED CONTENT11.08 mg
The reported net content is 10.8% above the 10 mg label. The certificate reports the measurement but does not state a numerical content acceptance range or assign a content pass/fail decision.
WHAT THE HEADLINE DOES NOT SAY
Four limits that belong beside the score.
One evidence category is absent
The reviewed certificate does not report heavy metals, residual solvents, targeted adulterants, or another contaminant panel. Identity and chromatographic purity do not answer those separate questions.
PCR is a targeted microbial screen
The report states “No Detectable Microbial DNA” under a PCR-based assay targeting common microbial contaminants. It does not describe a traditional growth-based USP <71> sterility study, so the exact method should remain visible.
The endotoxin result is threshold-based
The certificate reports two passing LAL replicates and assay sensitivity of ≤0.05 EU/mL. It does not print a separate numerical endotoxin result for the sample or establish a universal research-use acceptance threshold.
A matched certificate does not establish sampling
The client and lot fields support document-to-supplier traceability. They do not show how the submitted sample was selected, whether it represented saleable inventory, or whether another vial or future lot will match.
COMPOUND IQ VERDICT
A current, lot-matched 6/7 document—with a clearly missing contaminant panel.
This is one of the broader current public records we have reviewed: supplier, lot, dates, LC-MS identity, HPLC-UV purity, net content, PCR microbial screening, and USP <85>-referenced endotoxin testing are visible. It earns 6/7 document coverage because no broader contaminant panel appears. The score describes this certificate’s scope, not supplier quality, product safety, or suitability for use.
SOURCE DOCUMENTS
Inspect the evidence directly.
Read the original certificate, match any current vial to its exact lot, and do not extend this result to another batch or product.
TAKE THE FRAMEWORK WITH YOU
Review the next supplier with the same seven checks.
Download the Compound IQ checklist before opening another certificate. It keeps identity, content, lot traceability, methods, and missing panels visible.
Instant PDFSeven evidence checksUnsubscribe anytime
Instant PDF access. By subscribing, you agree to receive Compound IQ research education and occasional partner updates. Unsubscribe anytime.